Deprince Race & Zollo Inc Abb Vie Inc. Transaction History

Deprince Race & Zollo Inc

$5.18 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $39.9 Million - $49.5 Million	-302,336 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $4.47 Million - $5.65 Million	41,577 Added 15.94%	302,336 $40.9 Million
Q3 2021 Nov 17, 2021	SELL	$106.4 - $120.78 $494,547 - $561,385	-4,648 Reduced 1.75%	260,759 $28.1 Million
Q2 2021 Aug 12, 2021	SELL	$105.21 - $117.21 $953,728 - $1.06 Million	-9,065 Reduced 3.3%	265,407 $29.9 Million
Q1 2021 May 18, 2021	BUY	$102.3 - $112.62 $2.67 Million - $2.94 Million	26,082 Added 10.5%	274,472 $29.7 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $2.93 Million - $3.95 Million	36,340 Added 17.14%	248,390 $26.6 Million
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $465,975 - $546,901	5,424 Added 2.63%	212,050 $18.6 Million
Q2 2020 Aug 11, 2020	SELL	$73.37 - $98.18 $223,118 - $298,565	-3,041 Reduced 1.45%	206,626 $20.3 Million
Q1 2020 Apr 13, 2020	SELL	$64.5 - $97.79 $1.26 Million - $1.92 Million	-19,602 Reduced 8.55%	209,667 $16 Million
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $2.24 Million - $2.8 Million	-31,030 Reduced 11.92%	229,269 $20.3 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $19,523 - $23,473	310 Added 0.12%	260,299 $19.7 Million
Q2 2019 Aug 13, 2019	SELL	$65.7 - $83.98 $208,926 - $267,056	-3,180 Reduced 1.21%	259,989 $18.9 Million
Q1 2019 Apr 18, 2019	BUY	$77.14 - $90.79 $592,820 - $697,721	7,685 Added 3.01%	263,169 $0
Q4 2018 Jan 30, 2019	SELL	$77.85 - $96.01 $383,800 - $473,329	-4,930 Reduced 1.89%	255,484 $23.6 Million
Q3 2018 Oct 15, 2018	BUY	$88.91 - $98.84 $630,816 - $701,269	7,095 Added 2.8%	260,414 $24.6 Million
Q2 2018 Jul 17, 2018	SELL	$89.78 - $106.23 $1.25 Million - $1.48 Million	-13,950 Reduced 5.22%	253,319 $23.5 Million
Q1 2018 Apr 18, 2018	SELL	$92.01 - $123.21 $4.01 Million - $5.37 Million	-43,581 Reduced 14.02%	267,269 $25.3 Million
Q4 2017 Jan 26, 2018	SELL	$89.56 - $98.21 $3.87 Million - $4.24 Million	-43,177 Reduced 12.2%	310,850 $30.1 Million
Q3 2017 Nov 07, 2017	BUY	$69.85 - $89.22 $24.7 Million - $31.6 Million	354,027	354,027 $31.5 Million

Others Institutions Holding ABBV

# of Institutions

3,855

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deprince Race & Zollo Inc, based on Form 13F filings with the SEC.

News

Stay updated on Deprince Race & Zollo Inc with notifications on news.

Account